期刊文献+

巨大垂体腺瘤水钠代谢紊乱的围手术期处理

The Preioperative Management of Metabolic Disturbance of Water and Natrium for Patients with Giant Pituitary Adenomas
原文传递
导出
摘要 目的:总结巨大垂体腺瘤水钠代谢紊乱的围手术期处理经验。方法:对71例巨大垂体腺瘤患者术前及术后1周内每日检测血、尿电解质水平,以及血、尿渗透压,判断失钠及失水类型。总结不同瘤体大小与手术入路和水钠紊乱发生率、程度、时间之间的关系。结果:71例巨大垂体腺瘤患者中,出现水钠代谢紊乱52例,发生率73.2%。肿瘤大小与水钠紊乱发生率、严重程度、发生时间成正比,而手术入路选择与水钠代谢紊乱发生无明显相关。结论:巨大垂体腺瘤患者术后水钠代谢紊乱的发生与瘤体大小成正相关,其出现时间和表现形式复杂。对水钠代谢紊乱严重患者可适当予以预防性治疗,以减少临床症状和不良后果。 Objective:To summarize the preioperative management experience of metabolic disturbance of water and natrium for patients with giant pituitary adenomas.Methods:The electrolyte and osmotic pressure of blood and urine in patients with giant pituitary adenomas were detected within preoperative and postoperative one week and the type of the metabolic disturbance of water and natrium were determined.The correlation of the different tumor size and surgical approach with the incidence rate,extent and time of the metabolic disturbance was summarized.Results:There were 52 cases with different extent metabolic disturbance of water and natrium in 71 cases of giant pituitary adenomas (73.2%).There were a positive correlation of tumor size with the incidence rate,extent and time of the metabolic disturbance, and a negative correlation of surgical approach with that of the metabolic disturbance.Conclusion:The metabolic disturbance of water and natrium in giant pituitary adenomas was positive correlation with the tumor size, which is various in emergence time and pattern of manifestation.To reduce the clinical symptoms and adverse consequences, prophylactic treatment may be used in patients with serious metabolic disorder of water and natrium.
出处 《华西医学》 CAS 2009年第11期2845-2847,共3页 West China Medical Journal
基金 四川省科技厅项目(06SG0471)
关键词 巨大垂体腺瘤 水钠紊乱 围手术期 giant pituitary adenomas metabolic disturbance of water and natrium perioperative management
  • 相关文献

参考文献9

  • 1于春江,朱广廷,耿素民.巨大垂体腺瘤的显微外科治疗[J].中华医学杂志,2000,80(6):435-437. 被引量:38
  • 2REEDER RF, HARBAUGH RE. Administration of intravenous urea and normal saline for treatment of hyponatremia in neurosurgical patients[J]. J Neurosurg, 1989,70(2):206.
  • 3GROTE E. Characteristic of giant pituitary adenomas[J]. ACTA Neurochirurgica, 1982,60(3-4) : 141-153.
  • 4HANS P, STEVENAERT A, ALBERT A. Study of hypotonic polyuria after transsphenoidal pituitary adenomectomy[J]. Inten sire Care Med, 1986,12(2) : 95-99.
  • 5SAEKI N, HOSHI S, SUNADA S, et al. Correlation of high signal intensity of the pituitary stalk in macroadenoma and postopera tire diahetes[J]. AJNR, 2002,23(5) :822-827.
  • 6SEMPLE PL, LAWS ER. Complications in a contemporary series of patients who underssphenoidal surgery for Cushing'disease[J]. J Neurosurg, 1999,91(2) : 175-179.
  • 7刘运生,袁贤瑞,刘景平,陈立华,姜维喜,候永宏,王君宇,罗端午,潘力雄,曹美鸿.经眶-额下入路显微手术切除大型、巨大型垂体腺瘤技术探讨[J].中华神经外科杂志,2000,16(5):288-291. 被引量:49
  • 8KRISTOF RA, SCHRAMM J, REDEL L, et al. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH- and PRL secreting pituitary adenomas[J]. Acta Neurochir, 2002,144(6) :555-561.
  • 9VERBALIS JG. Management disorders of water metabolism in patients with pituitary tumors[J]. Pituitary, 2002,5(2) : 119-132.

二级参考文献5

共引文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部